Neurology

Neurology


Neurology is a branch of medicine dealing with neurological disorders.

What are neurological disorders?

Neurological diseasorders affect the central and peripheral nervous system. This includes the brain, spinal cord, cranial nerves, peripheral nerves, nerve roots, autonomic nervous system, neuromuscular junction, and muscles. Because these control all of the workings of the human body, symptoms are very visible and directly affect one's quality of life. Problems with movement, walking, speech, swallowing, breathing, or learning are common with these diseases. Additional issues include changes in memory, senses or mood. The causes can be diverse and include genetic abnormalities, bacterial, viral, fungal, and parasitic infections.

What medicines are there for neurological disorders?

Browse medicines that have been approved for specific neurological disorders by clicking on a specific disease. If a medicine has been approved by at least one reputable medical authority in the world is not available in your country, you may be able to purchase it via our service; we may be able to source and deliver it to you if you can provide a prescription from your doctor. 

  1. Radicut (edaravone) — FDA approved under the brand name Radicava
    Radicut (edaravone) — FDA approved under the brand name Radicava
    by Mitsubishi Tanabe Pharma Co., Ltd.
    for Amyotrophic Lateral Sclerosis (ALS), Cerebral Infarction
    €992.00
  2. Edaravone (generic)
    Edaravone (generic)
    by Daiichi Sankyo Company Limited
    for Cerebral Infarction
    €545.00
  3. Austedo (deutetrabenazine)
    Austedo (deutetrabenazine)
    by Teva Pharmaceuticals
    for Huntington's Disease, Tardive Dyskenia
    €4,485.00
  4. Calcort (deflazacort)
    Calcort (deflazacort)
    by Merrell Dow/Henning
    for Duchenne Muscular Dystrophy
    €11.44
  5. Fycompa (perampanel)
    Fycompa (perampanel)
    by Eisai Europe Ltd
    for Epilepsy
    €15.80
  6. Mavenclad (cladribine)
    Mavenclad (cladribine)
    by Merck Serono Europe Limited
    for Multiple Sclerosis
    €2,612.80
  7. Nuplazid (pimavanserin)
    Nuplazid (pimavanserin)
    by ACADIA Pharmaceuticals Inc
    for Parkinson's Disease
    €5,539.55
  8. Ocrevus (ocrelizumab)
    Ocrevus (ocrelizumab)
    by Roche Registration Limited
    for Multiple Sclerosis
    €8,682.50
  9. Ongentys (opicapone)
    Ongentys (opicapone)
    by Bial - Portela & Ca, S.A.
    for Parkinson's Disease
    €221.95
View as Grid List

Items 1-9 of 11

Page
per page
Set Descending Direction

One more step before you can continue

Our service contains information about acquiring medicines that have been approved in another country. This includes professional information such as approval details, product information and pricing. By scrolling, you are declaring that you are requesting any such information.

Scroll down.

No, I'd like to receive general information only.

Disclaimer: The information TSM provides is aimed at patients with terminal and life-debilitating diseases, their doctors and healthcare professionals. It supports an informed decision by the treating doctor about the patient’s treatment and the consideration of a medicine which has not been approved in the patient’s country.